DAVID F HALE
CIK 1024004 · Chairman · last filed 2026-01-06
DAVID F HALE is a Chairman who has filed 107 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for DRMAW, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$120.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $159.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$159.3K
8
107
-$120.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DRMAW | Director | 364 | $0.01 | $4 | $0 | 9 | 2026-01-06 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 30,387 | $0.53 | $16.0K | -$8.6K | 12 | 2024-06-24 |
| BIOCEPT INC (BIOC) Delisted | Director | 897 | $0.43 | $390 | $197.5K | 17 | 2021-12-10 |
| Histogen Inc. (CNAT) Delisted | Director | 36,363 | — | — | $28.5K | 8 | 2019-07-01 |
| SANTARUS INC (SNTS) Delisted | Director | 315,452 | — | — | $96.2K | 13 | 2013-06-12 |
| Pernix Sleep, Inc. (SOMX) Delisted | Director | 110,486 | — | — | -$289.6K | 25 | 2013-01-03 |
| MICROMET, INC. (MITI) Delisted | Director | 139,062 | — | — | -$168.3K | 15 | 2012-03-06 |
| MBRX | Director | 60,337 | $2.64 | $159.3K | $23.4K | 5 | 2009-06-25 |
Recent Filings
107 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | DRMAW | Grant (A) | — | $0 | EDGAR |
| 2025-01-23 | DRMAW | Grant (A) | +78,741 | $0 | EDGAR |
| 2025-01-14 | DRMAW | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-27 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Buy (P) | +980 | $8.9K | EDGAR |
| 2024-01-05 | DRMAW | Grant (A) | — | $0 | EDGAR |
| 2023-06-30 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-07 | DRMAW | Grant (A) | +30,155 | $0 | EDGAR |
| 2022-07-08 | DRMAW | Grant (A) | +26,441 | $0 | EDGAR |
| 2022-06-17 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |